Global Nanomedicine Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03249204

Publication Date:

March 12, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Nanomedicine market size was valued at US$ 152.1 million in 2023. With growing demand in downstream market, the Nanomedicine is forecast to a readjusted size of US$ 238.5 million by 2030 with a CAGR of 6.6% during review period.
The research report highlights the growth potential of the global Nanomedicine market. Nanomedicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nanomedicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nanomedicine market.
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.

Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.

In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.

Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
Key Features:
The report on Nanomedicine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nanomedicine market. It may include historical data, market segmentation by Type (e.g., Quantum dots, Nanoparticles), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nanomedicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nanomedicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nanomedicine industry. This include advancements in Nanomedicine technology, Nanomedicine new entrants, Nanomedicine new investment, and other innovations that are shaping the future of Nanomedicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nanomedicine market. It includes factors influencing customer ' purchasing decisions, preferences for Nanomedicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nanomedicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nanomedicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nanomedicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nanomedicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nanomedicine market.
Market Segmentation:
Nanomedicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Segmentation by application
oncology
Infectious diseases
Cardiology
Orthopedics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanomedicine Market Size 2019-2030
2.1.2 Nanomedicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nanomedicine Segment by Type
2.2.1 Quantum dots
2.2.2 Nanoparticles
2.2.3 Nanoshells
2.2.4 Nanotubes
2.2.5 Nanodevices
2.3 Nanomedicine Market Size by Type
2.3.1 Nanomedicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nanomedicine Market Size Market Share by Type (2019-2024)
2.4 Nanomedicine Segment by Application
2.4.1 oncology
2.4.2 Infectious diseases
2.4.3 Cardiology
2.4.4 Orthopedics
2.4.5 Others
2.5 Nanomedicine Market Size by Application
2.5.1 Nanomedicine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nanomedicine Market Size Market Share by Application (2019-2024)
3 Nanomedicine Market Size by Player
3.1 Nanomedicine Market Size Market Share by Players
3.1.1 Global Nanomedicine Revenue by Players (2019-2024)
3.1.2 Global Nanomedicine Revenue Market Share by Players (2019-2024)
3.2 Global Nanomedicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanomedicine by Regions
4.1 Nanomedicine Market Size by Regions (2019-2024)
4.2 Americas Nanomedicine Market Size Growth (2019-2024)
4.3 APAC Nanomedicine Market Size Growth (2019-2024)
4.4 Europe Nanomedicine Market Size Growth (2019-2024)
4.5 Middle East & Africa Nanomedicine Market Size Growth (2019-2024)
5 Americas
5.1 Americas Nanomedicine Market Size by Country (2019-2024)
5.2 Americas Nanomedicine Market Size by Type (2019-2024)
5.3 Americas Nanomedicine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nanomedicine Market Size by Region (2019-2024)
6.2 APAC Nanomedicine Market Size by Type (2019-2024)
6.3 APAC Nanomedicine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nanomedicine by Country (2019-2024)
7.2 Europe Nanomedicine Market Size by Type (2019-2024)
7.3 Europe Nanomedicine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nanomedicine by Region (2019-2024)
8.2 Middle East & Africa Nanomedicine Market Size by Type (2019-2024)
8.3 Middle East & Africa Nanomedicine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nanomedicine Market Forecast
10.1 Global Nanomedicine Forecast by Regions (2025-2030)
10.1.1 Global Nanomedicine Forecast by Regions (2025-2030)
10.1.2 Americas Nanomedicine Forecast
10.1.3 APAC Nanomedicine Forecast
10.1.4 Europe Nanomedicine Forecast
10.1.5 Middle East & Africa Nanomedicine Forecast
10.2 Americas Nanomedicine Forecast by Country (2025-2030)
10.2.1 United States Nanomedicine Market Forecast
10.2.2 Canada Nanomedicine Market Forecast
10.2.3 Mexico Nanomedicine Market Forecast
10.2.4 Brazil Nanomedicine Market Forecast
10.3 APAC Nanomedicine Forecast by Region (2025-2030)
10.3.1 China Nanomedicine Market Forecast
10.3.2 Japan Nanomedicine Market Forecast
10.3.3 Korea Nanomedicine Market Forecast
10.3.4 Southeast Asia Nanomedicine Market Forecast
10.3.5 India Nanomedicine Market Forecast
10.3.6 Australia Nanomedicine Market Forecast
10.4 Europe Nanomedicine Forecast by Country (2025-2030)
10.4.1 Germany Nanomedicine Market Forecast
10.4.2 France Nanomedicine Market Forecast
10.4.3 UK Nanomedicine Market Forecast
10.4.4 Italy Nanomedicine Market Forecast
10.4.5 Russia Nanomedicine Market Forecast
10.5 Middle East & Africa Nanomedicine Forecast by Region (2025-2030)
10.5.1 Egypt Nanomedicine Market Forecast
10.5.2 South Africa Nanomedicine Market Forecast
10.5.3 Israel Nanomedicine Market Forecast
10.5.4 Turkey Nanomedicine Market Forecast
10.5.5 GCC Countries Nanomedicine Market Forecast
10.6 Global Nanomedicine Forecast by Type (2025-2030)
10.7 Global Nanomedicine Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Combimatrix
11.1.1 Combimatrix Company Information
11.1.2 Combimatrix Nanomedicine Product Offered
11.1.3 Combimatrix Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Combimatrix Main Business Overview
11.1.5 Combimatrix Latest Developments
11.2 Ablynx
11.2.1 Ablynx Company Information
11.2.2 Ablynx Nanomedicine Product Offered
11.2.3 Ablynx Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Ablynx Main Business Overview
11.2.5 Ablynx Latest Developments
11.3 Abraxis Bioscience
11.3.1 Abraxis Bioscience Company Information
11.3.2 Abraxis Bioscience Nanomedicine Product Offered
11.3.3 Abraxis Bioscience Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abraxis Bioscience Main Business Overview
11.3.5 Abraxis Bioscience Latest Developments
11.4 Celgene
11.4.1 Celgene Company Information
11.4.2 Celgene Nanomedicine Product Offered
11.4.3 Celgene Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Celgene Main Business Overview
11.4.5 Celgene Latest Developments
11.5 Mallinckrodt
11.5.1 Mallinckrodt Company Information
11.5.2 Mallinckrodt Nanomedicine Product Offered
11.5.3 Mallinckrodt Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Mallinckrodt Main Business Overview
11.5.5 Mallinckrodt Latest Developments
11.6 Arrowhead Research
11.6.1 Arrowhead Research Company Information
11.6.2 Arrowhead Research Nanomedicine Product Offered
11.6.3 Arrowhead Research Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Arrowhead Research Main Business Overview
11.6.5 Arrowhead Research Latest Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Information
11.7.2 GE Healthcare Nanomedicine Product Offered
11.7.3 GE Healthcare Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GE Healthcare Main Business Overview
11.7.5 GE Healthcare Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Nanomedicine Product Offered
11.8.3 Merck Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Nanomedicine Product Offered
11.9.3 Pfizer Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Nanosphere
11.10.1 Nanosphere Company Information
11.10.2 Nanosphere Nanomedicine Product Offered
11.10.3 Nanosphere Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Nanosphere Main Business Overview
11.10.5 Nanosphere Latest Developments
11.11 Epeius Biotechnologies
11.11.1 Epeius Biotechnologies Company Information
11.11.2 Epeius Biotechnologies Nanomedicine Product Offered
11.11.3 Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Epeius Biotechnologies Main Business Overview
11.11.5 Epeius Biotechnologies Latest Developments
11.12 Cytimmune Sciences
11.12.1 Cytimmune Sciences Company Information
11.12.2 Cytimmune Sciences Nanomedicine Product Offered
11.12.3 Cytimmune Sciences Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Cytimmune Sciences Main Business Overview
11.12.5 Cytimmune Sciences Latest Developments
11.13 Nanospectra Biosciences
11.13.1 Nanospectra Biosciences Company Information
11.13.2 Nanospectra Biosciences Nanomedicine Product Offered
11.13.3 Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Nanospectra Biosciences Main Business Overview
11.13.5 Nanospectra Biosciences Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂